Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Dhanda

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Medical Research and Opinion|November 6, 2010
Cost-effectiveness of early compared to late inhaled nitric oxide therapy in near-term infantsEdward P Armstrong, Rahul Dhanda
Journal of Psychosomatic Research|September 24, 2009
Helplessness predicts the development of hypertension in older Mexican and European AmericansStephen L Stern, Rahul Dhanda, Helen P Hazuda
Journal of Neuro-Oncology|March 17, 2015
Clinical outcomes with bevacizumab-containing and non-bevacizumab-containing regimens in patients with recurrent glioblastoma from US community practicesClara Chen, Arliene Ravelo, Elaine Yu, et al.
Aging Clinical and Experimental Research|January 6, 2006
Development and validation of a performance-based measure of upper extremity functional limitationHelen P Hazuda, Rahul Dhanda, Steven V Owen, et al.
Journal of Medical Economics|January 4, 2021
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesiaMichael L Ganz, Ameya Chavan, Rahul Dhanda, et al.
Journal of Oncology Practice|August 15, 2013
Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancerClara Chen, Rahul Dhanda, Wan-Yu Tseng, et al.
Clinical Genitourinary Cancer|October 16, 2012
Everolimus vs. temsirolimus for advanced renal cell carcinoma: use and use of resources in the US Oncology NetworkNicholas J Vogelzang, Menaka Bhor, Zhimei Liu, et al.
Clinical Genitourinary Cancer|August 29, 2014
Dosing patterns, toxicity, and outcomes in patients treated with first-line sunitinib for advanced renal cell carcinoma in community-based practicesIan D Schnadig, Thomas E Hutson, Hsingwen Chung, et al.
Journal of the American Geriatrics Society|May 22, 2003
Barriers to and benefits of leisure time physical activity in the elderly: differences across culturesJeannae M Dergance, Walter L Calmbach, Rahul Dhanda, et al.
Sarcoma|April 1, 2014
Epidemiology, treatment patterns, and outcomes of metastatic soft tissue sarcoma in a community-based oncology networkClara Chen, Rohit Borker, James Ewing, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|November 6, 2010
Cost-effectiveness of early compared to late inhaled nitric oxide therapy in near-term infantsEdward P Armstrong, Rahul Dhanda
Journal of Psychosomatic Research|September 24, 2009
Helplessness predicts the development of hypertension in older Mexican and European AmericansStephen L Stern, Rahul Dhanda, Helen P Hazuda
Journal of Neuro-Oncology|March 17, 2015
Clinical outcomes with bevacizumab-containing and non-bevacizumab-containing regimens in patients with recurrent glioblastoma from US community practicesClara Chen, Arliene Ravelo, Elaine Yu, et al.
Aging Clinical and Experimental Research|January 6, 2006
Development and validation of a performance-based measure of upper extremity functional limitationHelen P Hazuda, Rahul Dhanda, Steven V Owen, et al.
Journal of Medical Economics|January 4, 2021
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesiaMichael L Ganz, Ameya Chavan, Rahul Dhanda, et al.
Journal of Oncology Practice|August 15, 2013
Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancerClara Chen, Rahul Dhanda, Wan-Yu Tseng, et al.
Clinical Genitourinary Cancer|October 16, 2012
Everolimus vs. temsirolimus for advanced renal cell carcinoma: use and use of resources in the US Oncology NetworkNicholas J Vogelzang, Menaka Bhor, Zhimei Liu, et al.
Clinical Genitourinary Cancer|August 29, 2014
Dosing patterns, toxicity, and outcomes in patients treated with first-line sunitinib for advanced renal cell carcinoma in community-based practicesIan D Schnadig, Thomas E Hutson, Hsingwen Chung, et al.
Journal of the American Geriatrics Society|May 22, 2003
Barriers to and benefits of leisure time physical activity in the elderly: differences across culturesJeannae M Dergance, Walter L Calmbach, Rahul Dhanda, et al.
Sarcoma|April 1, 2014
Epidemiology, treatment patterns, and outcomes of metastatic soft tissue sarcoma in a community-based oncology networkClara Chen, Rohit Borker, James Ewing, et al.
Pageof 3